Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Sebastiaan Horsman"'
Autor:
Peter A. Sillevis Smitt, Peter van der Spek, Johan M. Kros, Theo M. Luider, Martin J. van den Bent, Ivar Siccama, Elza Duijm, Sebastiaan Horsman, Justine Peeters, Pim J. French
Supplementary Figures 1-3 from Identification of Differentially Regulated Splice Variants and Novel Exons in Glial Brain Tumors Using Exon Expression Arrays
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bd120ff607b7dd0dee30b28afc88d6f
https://doi.org/10.1158/0008-5472.22366604
https://doi.org/10.1158/0008-5472.22366604
Autor:
Peter A. Sillevis Smitt, Peter van der Spek, Johan M. Kros, Theo M. Luider, Martin J. van den Bent, Ivar Siccama, Elza Duijm, Sebastiaan Horsman, Justine Peeters, Pim J. French
Supplementary Table 3 from Identification of Differentially Regulated Splice Variants and Novel Exons in Glial Brain Tumors Using Exon Expression Arrays
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61001e3928d9c75778323d37987bb21c
https://doi.org/10.1158/0008-5472.22366595.v1
https://doi.org/10.1158/0008-5472.22366595.v1
Autor:
Peter A. Sillevis Smitt, Peter van der Spek, Johan M. Kros, Theo M. Luider, Martin J. van den Bent, Ivar Siccama, Elza Duijm, Sebastiaan Horsman, Justine Peeters, Pim J. French
Supplementary Table 1 from Identification of Differentially Regulated Splice Variants and Novel Exons in Glial Brain Tumors Using Exon Expression Arrays
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98eda1fc2a0f3568d2e50da7121942c4
https://doi.org/10.1158/0008-5472.22366601.v1
https://doi.org/10.1158/0008-5472.22366601.v1
Autor:
Peter A. Sillevis Smitt, Peter van der Spek, Johan M. Kros, Theo M. Luider, Martin J. van den Bent, Ivar Siccama, Elza Duijm, Sebastiaan Horsman, Justine Peeters, Pim J. French
Aberrant splice variants are involved in the initiation and/or progression of glial brain tumors. We therefore set out to identify splice variants that are differentially expressed between histologic subgroups of gliomas. Splice variants were identif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::950b1de1add9b9c0e8893af9e022af31
https://doi.org/10.1158/0008-5472.c.6495215
https://doi.org/10.1158/0008-5472.c.6495215
Autor:
Peter A. Sillevis Smitt, Peter van der Spek, Johan M. Kros, Theo M. Luider, Martin J. van den Bent, Ivar Siccama, Elza Duijm, Sebastiaan Horsman, Justine Peeters, Pim J. French
Supplementary Table 2 from Identification of Differentially Regulated Splice Variants and Novel Exons in Glial Brain Tumors Using Exon Expression Arrays
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8597547b5e6fa94da808409bdeeb9442
https://doi.org/10.1158/0008-5472.22366598
https://doi.org/10.1158/0008-5472.22366598
Autor:
Johannes Waltenberger, Elizabeth A. McClellan, Laura Burgers, Joop Jukema, Imo E. Hoefer, A. C. Stubbs, Marieke A. Hillaert, Nico H.J. Pijls, Sebastiaan Horsman, Gerard Pasterkamp, Johan L. Severens, William K. Redekop
Publikováno v:
Netherlands Heart Journal, 24, 110-119. Bohn Stafleu van Loghum
Netherlands Heart Journal, 24(2), 110-119. Bohn Stafleu van Loghum
Netherlands Heart Journal, 24(2), 110. Bohn Stafleu van Loghum
Netherlands Heart Journal
Netherlands Heart Journal, 24(2), 110-119. Bohn Stafleu van Loghum
Netherlands Heart Journal, 24(2), 110. Bohn Stafleu van Loghum
Netherlands Heart Journal
Aim Variations in treatment are the result of differences in demographic and clinical factors (e.g. anatomy), but physician and hospital factors may also contribute to treatment variation. The choice of treatment is considered important since it coul
Autor:
Marieke A. Hillaert, Erik A.L. Biessen, W. Ken Redekop, Johannes Waltenberger, Pieter A. Doevendans, Andrew P. Stubbs, J. Wouter Jukema, Elizabeth A. McClellan, Imo E. Hoefer, Philip G. de Groot, Nico H.J. Pijls, Eric Van De Veer, Mat J.A.P. Daemen, Peter J. van der Spek, Mustafa Ilhan, Jan Willem Sels, Johan Kuiper, Anton Jan van Zonneveld, Sandrin C. Bergheanu, Sebastiaan Horsman, Gerard Pasterkamp
Publikováno v:
Clinical research in cardiology, 102(11), 847-856. Springer
Clinical Research in Cardiology, 102, 847-856. D. Steinkopff-Verlag
Clinical Research in Cardiology, 102(11), 847-856. Springer
Clinical research in cardiology, 102(11), 847-856. D. Steinkopff-Verlag
Clinical Research in Cardiology, 102(11), 847-856
Clinical Research in Cardiology, 102, 847-856. D. Steinkopff-Verlag
Clinical Research in Cardiology, 102(11), 847-856. Springer
Clinical research in cardiology, 102(11), 847-856. D. Steinkopff-Verlag
Clinical Research in Cardiology, 102(11), 847-856
Biomarkers for primary or secondary risk prediction of cardiovascular disease (CVD) are urgently needed to improve individual treatment and clinical trial design. The vast majority of biomarker discovery studies has concentrated on plasma/serum as an
Autor:
Ivar Siccama, Theo M. Luider, Martin J. van den Bent, Peter A. E. Sillevis Smitt, Elza Duijm, Justine K. Peeters, Sebastiaan Horsman, Johan M. Kros, Pim J. French, Peter J. van der Spek
Publikováno v:
Cancer Research, 67(12), 5635-5642. American Association for Cancer Research Inc.
Aberrant splice variants are involved in the initiation and/or progression of glial brain tumors. We therefore set out to identify splice variants that are differentially expressed between histologic subgroups of gliomas. Splice variants were identif
Autor:
Martijn H. Brugman, Gerard Wagemaker, Andrew P. Stubbs, Sebastiaan Horsman, Marshall W. Huston, Peter J. van der Spek
Publikováno v:
Human Gene Therapy, 23(11), 1209-1219. Mary Ann Liebert Inc.
Human Gene Therapy
Human Gene Therapy; Vol 23
Human Gene Therapy
Human Gene Therapy; Vol 23
Introducing therapeutic genes into hematopoietic stem cells using retroviral vector-mediated gene transfer is an effective treatment for monogenic diseases. The risks of therapeutic gene integration include aberrant expression of a neighboring gene,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f1fc7e98c31e17ee05f96f151e2ff39
https://pure.eur.nl/en/publications/3f43db78-815a-437d-8e9a-888b924b132f
https://pure.eur.nl/en/publications/3f43db78-815a-437d-8e9a-888b924b132f
Autor:
Sigrid M.A. Swagemakers, Daphne Heijsman, Elizabeth A. McClellan, Jules P.P. Meijerink, Joke Reumers, Andrew P. Stubbs, Peter J. van der Spek, Sebastiaan Horsman, Saskia Hiltemann, Frits Hoogland, Stephan Nouwens, Andreas Kremer, Anton H. Koning, Ivo Palli, Diether Lambrechts
Publikováno v:
Journal of Clinical Bioinformatics, 2(1). BioMed Central Ltd.
Journal of Clinical Bioinformatics
EUR Research Portal
Journal of Clinical Bioinformatics
EUR Research Portal
Background Next generation sequencing provides clinical research scientists with direct read out of innumerable variants, including personal, pathological and common benign variants. The aim of resequencing studies is to determine the candidate patho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cb50c267157a7417e65f51c6e93fe3b
https://pure.eur.nl/en/publications/7c64b89b-8b0e-4fec-a22a-ca65ad03fbb7
https://pure.eur.nl/en/publications/7c64b89b-8b0e-4fec-a22a-ca65ad03fbb7